This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biological E Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations in High-Level Production: The Contributions of Balamurali Masilamani
Introduction
Balamurali Masilamani, an innovative inventor based in Telangana, India, has made significant strides in the field of biotechnology. His unique approach to enhancing production methods has resulted in a notable patent that highlights his expertise and commitment to research and development.
Latest Patents
Masilamani holds one patent titled "Method for High Level Production of CRM." This invention provides an improved method for the high-yield production of CRM by utilizing an engineered strain with an increased copy number of the CRM gene. The methodology emphasizes growing this strain in media that is free of animal-derived components and incorporates one or more amino acids, presenting a sustainable and efficient solution to bioproduction.
Career Highlights
Balamurali is currently employed at Biological E Limited, a prominent biotechnology company known for its contributions to vaccine development and other biopharmaceuticals. His work at this esteemed institution allows him to explore innovative applications in the life sciences, driving forward the frontier of medical research.
Collaborations
In his professional journey, Masilamani has collaborated with notable colleagues such as Rajan Sriraman and Mandar Shirish Dixit. These collaborations foster an environment of shared knowledge and diverse insights, further enhancing the potential for groundbreaking discoveries in their respective fields.
Conclusion
Balamurali Masilamani is a key player in the landscape of biotechnology innovation. His patent not only reflects his individual contributions but also serves as a testament to the collaborative efforts within his organization. As he continues to advance methods of production in the biopharmaceutical sector, the impact of his work is poised to resonate within the industry for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
